Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
MedTech
Roche, Eli Lilly net FDA approval for Alzheimer’s biomarker test
Roche and Eli Lilly have secured FDA clearance for their latest Alzheimer’s disease diagnostic.
Ben Adams
Aug 24, 2026 8:15am
FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify
Aug 17, 2026 7:51am
MapLight turns off preclinical tap to fund schizophrenia drug
Aug 14, 2026 4:38am
AAIC: Roche ‘very interested’ in tau despite amyloid AD focus
Jul 15, 2026 8:42am
Biogen defends anti-tau drug after stock slide
Jul 14, 2026 2:00pm
AAIC: Biogen bolsters hopes for pivotal anti-tau push
Jul 14, 2026 9:15am
